PET/CT

PET imaging has grown over the past two decades to become a mainstay in the diagnosis and management of cancer patients. While oncology scans continue to comprise the majority of PET scans, new radiopharmaceuticals offer the promise of increasing the efficacy of PET imaging for cardiology and neurology.

IMV’s 2026 PET Imaging Outlook Summary Report…

IMV’s 2023 Oncology in Diagnostic Imaging Market Outlook Report explores oncology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, Mammography, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, trends, and site operations characteristics. Survey results are projected to the identified universe of…